Covering the business of education and training

In 1989, a Brigham Young University professor discovered an enzyme that might lead to a painkiller that didn't cause stomach problems while reducing inflammation.

Instead of patenting his finding, he decided to TRUST the findings to a drugmaker - Pfizer.

Fastforward 17 years. The professor was right. The pharmaceutical giant, Pfizer, used the findings to the tune of $20 billion or more in sales.

The professor and the university want a piece of that and credit given to the prof for making the finding in the first place.

The brand name for the drug is Celebrex.

Years of behind the door negotiations have proven fruitless. It seems Pfizer would rather some law group share in the payment to the professor than just give BYU and the professor their due.

So...in the end, the lawyers will win, no matter the outcome.

It'll be interesting to see how the case turns out. The lawyers will be interested, too.

What do you think?